| abstract |
The present invention discloses a compound with the following formula (I), as well as tautomers, stereoisomers, isotopic isomers and pharmaceutically acceptable salts of the compounds represented by the formula (I): wherein R 1 , rings A, L, W, V and G are defined herein. The present invention also discloses the use of the compound represented by formula (I), or the tautomer, stereoisomer, isotopic isomer or salt of the compound represented by formula (I), and a pharmaceutical composition containing them for treatment Methods of diseases or disorders mediated by Tyro3, Axl and/or Mer kinases. |